Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
351 USD | +1.04% | +1.88% | +17.20% |
May. 06 | UBS Adjusts Cigna Price Target to $410 From $400, Maintains Buy Rating | MT |
May. 06 | Jefferies Adjusts Price Target on Cigna to $407 From $385, Keeps Buy Rating | MT |
Financials (USD)
Sales 2024 * | 235B | Sales 2025 * | 247B | Capitalization | 98.67B |
---|---|---|---|---|---|
Net income 2024 * | 5.3B | Net income 2025 * | 7.16B | EV / Sales 2024 * | 0.51 x |
Net Debt 2024 * | 21.24B | Net Debt 2025 * | 17.43B | EV / Sales 2025 * | 0.47 x |
P/E ratio 2024 * |
17.8
x | P/E ratio 2025 * |
13.3
x | Employees | 71,413 |
Yield 2024 * |
1.61% | Yield 2025 * |
1.72% | Free-Float | 69.59% |
Latest transcript on Cigna
1 day | +1.04% | ||
1 week | +1.88% | ||
Current month | -1.70% | ||
1 month | -1.82% | ||
3 months | +4.79% | ||
6 months | +21.48% | ||
Current year | +17.20% |
Managers | Title | Age | Since |
---|---|---|---|
David Cordani
CEO | Chief Executive Officer | 58 | 90-12-31 |
Brian Evanko
DFI | Director of Finance/CFO | 48 | - |
Paul Sanford
COO | Chief Operating Officer | - | 21-09-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 17-12-31 | |
David Cordani
CEO | Chief Executive Officer | 58 | 90-12-31 |
Donna Zarcone
BRD | Director/Board Member | 66 | 04-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.33% | 0 M€ | -.--% | ||
2.28% | 0 M€ | +5.54% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 347.4 | +0.19% | 1,355,254 |
24-05-07 | 346.7 | +1.25% | 1,567,974 |
24-05-06 | 342.4 | +0.27% | 1,339,270 |
24-05-03 | 341.5 | -0.87% | 2,413,548 |
24-05-02 | 344.5 | -3.55% | 3,108,825 |
Delayed Quote Nyse, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.20% | 98.67B | |
-3.69% | 463B | |
+4.64% | 40.48B | |
-26.90% | 39.06B | |
-3.12% | 20.18B | |
-12.59% | 3.09B | |
-19.74% | 1.3B | |
-9.33% | 432M |
- Stock Market
- Equities
- CI Stock